mRNA-Based Vaccines.
cancer
delivery systems
infectious disease
lipid nanoparticles
mRNA
vaccine constructs
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
received:
17
03
2021
revised:
09
04
2021
accepted:
13
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Increases in the world's population and population density promote the spread of emerging pathogens. Vaccines are the most cost-effective means of preventing this spread. Traditional methods used to identify and produce new vaccines are not adequate, in most instances, to ensure global protection. New technologies are urgently needed to expedite large scale vaccine development. mRNA-based vaccines promise to meet this need. mRNA-based vaccines exhibit a number of potential advantages relative to conventional vaccines, namely they (1) involve neither infectious elements nor a risk of stable integration into the host cell genome; (2) generate humoral and cell-mediated immunity; (3) are well-tolerated by healthy individuals; and (4) are less expensive and produced more rapidly by processes that are readily standardized and scaled-up, improving responsiveness to large emerging outbreaks. Multiple mRNA vaccine platforms have demonstrated efficacy in preventing infectious diseases and treating several types of cancers in humans as well as animal models. This review describes the factors that contribute to maximizing the production of effective mRNA vaccine transcripts and delivery systems, and the clinical applications are discussed in detail.
Identifiants
pubmed: 33921028
pii: vaccines9040390
doi: 10.3390/vaccines9040390
pmc: PMC8103517
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Immunol Res. 2015;2015:797421
pubmed: 26557723
Expert Rev Vaccines. 2015 Feb;14(2):161-76
pubmed: 25196947
Nat Rev Mol Cell Biol. 2018 Mar;19(3):158-174
pubmed: 29165424
Front Pharmacol. 2018 Aug 21;9:971
pubmed: 30186185
Mol Cell Biol. 1996 Jan;16(1):146-56
pubmed: 8524291
Nature. 2020 Sep;585(7823):107-112
pubmed: 32728218
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Front Oncol. 2019 Jun 13;9:500
pubmed: 31263676
Immunity. 2005 Aug;23(2):165-75
pubmed: 16111635
Adv Drug Deliv Rev. 2020;159:364-376
pubmed: 32298783
Hum Vaccin Immunother. 2013 Oct;9(10):2263-76
pubmed: 23921513
Mol Ther. 2019 Apr 10;27(4):757-772
pubmed: 30803823
Methods Mol Biol. 2017;1499:89-107
pubmed: 27987144
Nat Struct Mol Biol. 2017 Dec;24(12):1057-1063
pubmed: 29106412
Vaccine. 2016 Jan 2;34(1):110-9
pubmed: 26555351
Sci Rep. 2017 Mar 21;7(1):252
pubmed: 28325910
Recent Results Cancer Res. 2016;209:61-85
pubmed: 28101688
Vaccines (Basel). 2021 Jan 19;9(1):
pubmed: 33478109
Mol Ther Nucleic Acids. 2019 Apr 15;15:1-11
pubmed: 30785039
Cell. 2017 Mar 9;168(6):1114-1125.e10
pubmed: 28222903
Nat Rev Mol Cell Biol. 2008 Apr;9(4):337-44
pubmed: 18334997
Nucleic Acid Ther. 2018 Jun;28(3):158-165
pubmed: 29688817
Mol Ther. 2018 Feb 7;26(2):446-455
pubmed: 29275847
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):596-601
pubmed: 26733676
NPJ Vaccines. 2017 Oct 19;2:29
pubmed: 29263884
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4133-42
pubmed: 27382155
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
Cancer Res. 1995 Apr 1;55(7):1397-400
pubmed: 7882341
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Vaccine. 2019 May 31;37(25):3326-3334
pubmed: 31079849
Science. 2021 Mar 12;371(6534):1152-1153
pubmed: 33514629
Nanomedicine. 2011 Aug;7(4):445-53
pubmed: 21220051
RNA Biol. 2012 Nov;9(11):1319-30
pubmed: 23064118
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
Nat Rev Drug Discov. 2014 Oct;13(10):759-80
pubmed: 25233993
Curr Top Microbiol Immunol. 2022;440:71-110
pubmed: 32483657
Pediatr Allergy Immunol. 2018 Nov;29(7):679-688
pubmed: 30063806
Development. 2016 Jun 1;143(11):1838-47
pubmed: 27246710
Mol Cell. 2019 May 2;74(3):508-520.e4
pubmed: 30902547
Ther Deliv. 2016;7(5):319-34
pubmed: 27075952
Nat Commun. 2018 Jul 6;9(1):2629
pubmed: 29980667
J Biol Chem. 1995 Mar 17;270(11):6298-307
pubmed: 7534310
Lancet. 2017 Sep 23;390(10101):1511-1520
pubmed: 28754494
Vaccine. 2017 Jul 24;35(33):4064-4071
pubmed: 28647170
Nucleic Acids Res. 2011 Nov;39(21):e142
pubmed: 21890902
Nucleic Acids Res. 1987 Nov 11;15(21):8783-98
pubmed: 3684574
Nat Biotechnol. 2010 Feb;28(2):172-6
pubmed: 20081866
Mol Ther. 2017 Dec 6;25(12):2635-2647
pubmed: 28958578
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Expert Rev Vaccines. 2015 Feb;14(2):177-94
pubmed: 25269775
Mol Ther. 2015 Sep;23(9):1456-64
pubmed: 26050989
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Vaccines (Basel). 2019 Sep 27;7(4):
pubmed: 31569785
J Immunol. 2017 May 15;198(10):4012-4024
pubmed: 28416600
Trends Biotechnol. 2004 Jul;22(7):346-53
pubmed: 15245907
PLoS One. 2013;8(3):e57755
pubmed: 23526951
Lancet. 2021 Feb 6;397(10273):462
pubmed: 33549181
Nature. 2017 Mar 9;543(7644):248-251
pubmed: 28151488
N Engl J Med. 2020 Sep 17;383(12):1191-1192
pubmed: 32813942
JAMA. 2021 Feb 23;325(8):780-781
pubmed: 33475702
Nat Rev Immunol. 2021 Feb;21(2):83-100
pubmed: 33353987
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Hum Vaccin Immunother. 2014;10(11):3146-52
pubmed: 25483661
Curr Opin Immunol. 2020 Aug;65:14-20
pubmed: 32244193
Mol Ther. 2014 Dec;22(12):2118-2129
pubmed: 25027661
Nat Rev Immunol. 2020 Sep;20(9):517
pubmed: 32753762
Vaccine. 2021 Feb 22;39(8):1310-1318
pubmed: 33487468
Front Immunol. 2018 Sep 19;9:1963
pubmed: 30283434
Mol Ther. 2019 Apr 10;27(4):710-728
pubmed: 30846391
Mol Ther Nucleic Acids. 2016 Jun 21;5(6):e326
pubmed: 27327138
Curr Opin Immunol. 2016 Apr;39:14-22
pubmed: 26716729
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
Cell. 2009 Feb 20;136(4):763-76
pubmed: 19239894
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6077-81
pubmed: 2762315
Methods Mol Biol. 2017;1499:193-200
pubmed: 27987151
Immunobiology. 2006;211(6-8):599-608
pubmed: 16920498
NPJ Vaccines. 2020 Feb 4;5:11
pubmed: 32047656
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Mol Ther. 2013 Jan;21(1):251-9
pubmed: 23011030
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Pharmaceutics. 2020 Dec 30;13(1):
pubmed: 33396817
Hum Gene Ther. 2009 Oct;20(10):1106-18
pubmed: 19656053